Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 938250211 | 9382502 | 11 | F | 20160722 | 20130703 | 20160728 | EXP | US-GLAXOSMITHKLINE-A1026998A | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 938250211 | 9382502 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 37 NG/KG/MIN (CONCENTRATION 30,000 NG/ML, PUMP RATE UNKNOWN ML/DAY, AND VIAL STRENGTH 1.5MG)17 [...] | U | P057 | 20444 | 37 | DF | POWDER FOR INFUSION | |||||
| 938250211 | 9382502 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | R852 | 20444 | POWDER FOR INFUSION | ||||||||
| 938250211 | 9382502 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | R614 | 20444 | POWDER FOR INFUSION | ||||||||
| 938250211 | 9382502 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | S562 | 20444 | POWDER FOR INFUSION | ||||||||
| 938250211 | 9382502 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 47 NG/KG/MIN CONTINUOUSLY | U | U631 | 20444 | 47 | DF | POWDER FOR INFUSION | ||||||
| 938250211 | 9382502 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK, CO | U | U893 | 20444 | POWDER FOR INFUSION | |||||||
| 938250211 | 9382502 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 47 NG/KG/MIN (CONCENTRATION 60,000 NG/ML, PUMP RATE 73 ML/HR, VIAL STRENGTH 1.5 MG), CO | U | V049 | 20444 | 47 | DF | POWDER FOR INFUSION | |||||
| 938250211 | 9382502 | 8 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | 20444 | POWDER FOR INFUSION | |||||||||
| 938250211 | 9382502 | 9 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | U | 20444 | POWDER FOR INFUSION | |||||||||
| 938250211 | 9382502 | 10 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 47 NG/KG/MIN | U | V049 | 20444 | 47 | DF | POWDER FOR INFUSION | ||||||
| 938250211 | 9382502 | 11 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 47 NG/KG/MIN, CONTINUOUS | U | Z111 | 20444 | 47 | DF | POWDER FOR INFUSION | ||||||
| 938250211 | 9382502 | 12 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | U | 0 | SOLUTION FOR INJECTION | ||||||||||
| 938250211 | 9382502 | 13 | SS | ADCIRCA | TADALAFIL | 1 | 2 DF, QD | U | 0 | 2 | DF | QD | |||||||
| 938250211 | 9382502 | 14 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
| 938250211 | 9382502 | 15 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 938250211 | 9382502 | 1 | Pulmonary arterial hypertension |
| 938250211 | 9382502 | 12 | Pulmonary arterial hypertension |
| 938250211 | 9382502 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 938250211 | 9382502 | HO |
| 938250211 | 9382502 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 938250211 | 9382502 | Abdominal discomfort | |
| 938250211 | 9382502 | Adverse event | |
| 938250211 | 9382502 | Asthenia | |
| 938250211 | 9382502 | Chest pain | |
| 938250211 | 9382502 | Confusional state | |
| 938250211 | 9382502 | Cough | |
| 938250211 | 9382502 | Diarrhoea | |
| 938250211 | 9382502 | Disease complication | |
| 938250211 | 9382502 | Dyspnoea | |
| 938250211 | 9382502 | Fluid retention | |
| 938250211 | 9382502 | Gait disturbance | |
| 938250211 | 9382502 | Headache | |
| 938250211 | 9382502 | Investigation | |
| 938250211 | 9382502 | Mental status changes | |
| 938250211 | 9382502 | Nausea | |
| 938250211 | 9382502 | Nervous system disorder | |
| 938250211 | 9382502 | Pain in extremity | |
| 938250211 | 9382502 | Pain in jaw | |
| 938250211 | 9382502 | Plasmapheresis | |
| 938250211 | 9382502 | Pulmonary arterial hypertension | |
| 938250211 | 9382502 | Suture related complication | |
| 938250211 | 9382502 | Vomiting | |
| 938250211 | 9382502 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 938250211 | 9382502 | 1 | 20080927 | 0 | ||
| 938250211 | 9382502 | 2 | 20080927 | 0 | ||
| 938250211 | 9382502 | 3 | 20080927 | 0 | ||
| 938250211 | 9382502 | 4 | 20080927 | 0 | ||
| 938250211 | 9382502 | 10 | 20140327 | 0 | ||
| 938250211 | 9382502 | 11 | 20140327 | 0 |